DUBLIN–(BUSINESS WIRE)–The “CRO Quality Benchmarking – Phase IV Service Providers (12th Edition)” report has been added to ResearchAndMarkets.com’s offering.
The report aims to take two of the most challenging and time-consuming processes out of the abstract for outsourcers: CRO selection and CRO performance evaluation.
Which provider is best to conduct a given trial? Who will perform the best? Insights from 111 experienced Phase IV outsourcers and nearly 300 service provider encounters are framed in this quality benchmarking report, addressing these questions.
We leave no stone unturned by giving a sense of a provider’s brand positioning, customer loyalty, and attribute-specific strengths and weaknesses. Let us take the mystery and stress out of your Phase IV service provider selection process.
Both sponsors and providers can use this research to glean what they need to make the best decisions possible for their clinical development programs and service offerings. Informed decisions are indeed the best decisions.
What You Will Learn:
Sponsors:
- Discover which service providers your company should consider for your Phase IV studies by understanding how CROs have performed relative to your peers’ expectations
- Gain insight into CRO customer loyalty based on overall customer satisfaction, willingness to recommend and likelihood to use again
- Learn which provider attributes drive provider selection and explore verbatim responses from recent customers on CRO performance
Service Providers:
- Compare how your company and your competitors have performed for recent customers across 6 attributes and 14 study types
- Learn how to improve your marketing messaging by focusing on the areas in which customers say you excel
- Find out which factors affect sponsor outsourcing preferences and which factors are gaining in importance for future outsourcing
Major Topics:
- Service Provider Selection Process
- Service Provider Perceptions and Interactions
- Study Data
- Service Provider Drill Downs
Key Topics Covered:
1. Service Provider Selection Process
- Primary Section Takeaways
- Preferred Provider Agreements
- Selection Attributes
- Use of Outside Consultants
- Select Respondent Comments
2. Service Provider Perceptions and Interactions
- Primary Section Takeaways
- Phase IV Leadership, Familiarity, and Use
- Service Provider Preference
- Service Provider Preference among Users
- Cost Perceptions
- Summary Table
- Customer Loyalty
- Customer Loyalty: 3-Year Rolling Average
3. Study Data
- Phase IV Leaders, Unprompted
- Other Responses
- Phase IV Leaders, Prompted
- Service Provider Familiarity
- Service Provider Usage
- Service Provider Preference
- Service Provider Differentiation
- Service Provider Cost Perceptions
- Use of Preferred Providers
- Number of Preferred Providers
- Selection Drivers: Selecting among Preferred Providers
- Preferred Provider Attributes Gaining Importance
- Selection Drivers: When Not Using Preferred Providers
- Selection Drivers: No Preferred Providers
- Service Provider Attributes Gaining Importance: No Preferred Providers
- Use of Outside Consultants
- Outside Consultant Assistance
4. Service Provider Drill-downs
- Catalyst Clinical Research
- Clinipace
- Covance
- CTI Clinical Trial & Consulting
- DaVita Clinical Research
- DCRI-Duke
- Eurofins
- ICON
- Innovaderm
- IQVIA
- Medpace
- Medsource
- Ora
- Parexel
- Pharm-Olam International
- PPD
- PRA
- PSI
- QPS
- Rho
- RTI International
- SGS Life Sciences
- Syneos Health
- UBC
- Worldwide Clinical Trials
5. Demographics
- Company Type
- Headquarters Location
- Office Location
- Job Title
- Decision-making Responsibility
- Outsourcing Involvement by Phase
- Involvement in Clinical Development
- Therapeutic Areas of Responsibility
- Years of Industry Experience
- Age
For more information about this report visit https://www.researchandmarkets.com/r/l58kjw
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900